Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN65166542
ISRCTN65166542
Completed
Not Applicable

Are autotransfusion drains effective for total knee arthroplasty? A randomised controlled trial

Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)0 sites100 target enrollmentSeptember 30, 2004
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Enrollment
100
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2004
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • •100 patients will be selected for this study. All patients will need total knee replacements.

Exclusion Criteria

  • •Patients with bleeding disorders, Jehovah's witnesses and those not wishing to enter the study will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Post-operative autologous transfusion of filtered shed blood in total knee arthroplasty: clinical bloodmanagement in everyday orthopaedic practiceTKA, transfusion, blood, autoloog
NL-OMON21964A/Orbis750
Completed
Not Applicable
Autologous Transfusion In Surgery: a randomised clinical trialCardiovascular diseases: Peripheral arterial diseaseCirculatory SystemPeripheral arterial disease
ISRCTN85756518HS R&D Regional Programme Register - Department of Health (UK)
Not yet recruiting
Not Applicable
Autologous whole blood injection as treatment for Covid-19 infectioHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/09/027904Dr M Christopher
Recruiting
Phase 3
se of stem cells which have capacity to grow to liver cells in patients of cirrhosis of liver who have jaundice, ascites( water in abdomen)
CTRI/2017/11/010429Asian Healthcare Foundation
Recruiting
Phase 1
Efficacy and safety of hemodilutional autologous blood transfusion for intermediate- to advanced- liver resection : An observational studyAll disease which would be required for hepatectomyhepatectomy, hemodilutionalautologous blood transfusion (HAT)
JPRN-jRCT1050220063chida Yoichiro50